Nalaganje...
Pharmacogenomics in bladder cancer
Bladder cancer is a common cancer worldwide. For patients presenting with muscle-invasive disease, the five year survival rate is approximately 50%. Cisplatinum-based combination chemotherapy is recommended in the neoadjuvant setting prior to cystectomy and is also the first line in the metastatic s...
Shranjeno v:
| Main Authors: | , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
2014
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3904434/ https://ncbi.nlm.nih.gov/pubmed/24360659 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.urolonc.2013.09.007 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|